Core Viewpoint - A class action lawsuit has been filed against Canopy Growth Corporation for allegedly misleading investors regarding its cost reduction measures and financial performance during a specified period [1][2]. Allegations - The lawsuit claims that Canopy Growth Corporation failed to disclose significant costs associated with the production of Claybourne pre-rolled joints and indirect costs related to Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and overall financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures while downplaying issues related to its gross margins [2]. Financial Impact - On February 7, 2025, Canopy announced disappointing financial results attributed to the costs from the Claybourne product launch and increased indirect costs, leading to a 27.24% drop in share price, closing at $2.02 [3]. Class Action Participation - Shareholders may be eligible to participate in the class action against Canopy Growth Corporation, with a deadline for lead plaintiff applications set for June 3, 2025 [4]. Company Background - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].

Toronto, Ontario--(Newsfile Corp. - March 27, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce that it has closed its non-brokered financing previously announced on March 10, 2025. The Company issued 8,823,529 charity flow-through shares (the "Charity FT Shares") at a price of $0.28 per Charity FT Share and 2,941,176 common share units (the "Share Units") at a price of $0.17 per Share Unit for aggregate gross proceeds to the Company of approximately $3 milli ...

Core Insights - Canadian cannabis stocks are under close observation due to their ties to the expanding U.S. market, which could reach $72 billion by 2030 [1][21] - The U.S. Department of Health and Human Services has recommended rescheduling cannabis to Schedule III, increasing optimism for federal reform [1] - Key Canadian companies with U.S. exposure include Tilray Brands, Canopy Growth Corporation, and Village Farms International, each with distinct strategies and financial positions [3][21] Group 1: Tilray Brands, Inc. (TLRY) - Tilray is a prominent player in the global cannabis market, focusing on strategic partnerships and acquisitions in the U.S. despite federal restrictions [4][6] - The company reported revenue of $177 million, a 34% year-over-year increase, driven by beverage and wellness sales, while cannabis revenue grew modestly [8] - Tilray's long-term strategy aims for profitability and a strong position in cannabis, wellness, and beverages, with a $20 million share repurchase program indicating confidence in future performance [7][9] Group 2: Canopy Growth Corporation (CGC) - Canopy Growth, once the largest cannabis stock in Canada, is now focused on profitability and capturing U.S. market share through investments in Acreage Holdings and Wana Brands [9][11] - The company reported revenue of $62 million, a 21% year-over-year decline, with net losses of $216 million, although it showed improvement in U.S. CBD and wellness divisions [13] - Canopy is restructuring to save $100 million annually and is simplifying its business model to focus on high-growth segments [14][15] Group 3: Village Farms International, Inc. (VFF) - Village Farms operates in both cannabis and produce industries, providing a buffer against cannabis market volatility [15][16] - The company reported revenue of $71 million, with cannabis sales contributing $29 million, and a net loss of $9.5 million, which was narrower than previous losses [18][20] - Village Farms is committed to cost discipline and has a strong balance sheet, ending the quarter with over $20 million in cash and minimal debt, positioning it well for future growth [20]

Core Insights - Wana Brands has launched its hemp-derived Delta-9 THC gummies in Texas, marking the 22nd state for product availability, emphasizing the company's commitment to safe and reliable cannabis products [1][2] - The expansion into Texas aligns with the evolving cannabis landscape in the state, allowing Wana to meet consumer demand through strategic retail placements [2] - Wana Brands prioritizes quality and safety, with all products undergoing rigorous third-party testing for potency, purity, and contaminants [3] Company Strategy - The expansion beyond the Wanderous marketplace is a key growth strategy for Wana, aiming to capture market share by increasing product accessibility at local retail locations [4] - Wana's mission focuses on enhancing lives through plant-powered products and providing consumers with the education needed for informed choices [4] Company Background - Wana is recognized as North America's most trusted edibles brand, with a presence in multiple U.S. states, Puerto Rico, and Canada, founded in 2010 [5] - Canopy USA, the parent company of Wana, holds a non-controlling interest in Canopy Growth and is strategically positioned in high-potential segments of the U.S. cannabis market [6]

Strategic Partnership Increases Consumer Availability for Premium Cannabis BeveragesBOULDER, Colo., March 12, 2025 /PRNewswire/ -- Wana Brands, North America's leading edibles provider and a subsidiary of Canopy USA LLC ("Canopy USA"), today announced that Wana Beverages are now available at Total Wine & More locations nationwide, highlighting the increasing consumer demand for health-conscious, zero-proof alcohol alternatives. Wana Beverages, a hemp-infused line of ready-to-drink sparkling beverages cra ...

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices by Canopy Growth Corporation and its officers or directors [1] Financial Performance - On February 7, 2025, Canopy Growth Corporation reported its financial results for Q3 of fiscal year 2025, showing year-over-year declines in both net revenue and gross margin, leading to a wider-than-expected net loss for the quarter [2] - Following the financial report, Canopy's stock price dropped by $0.76 per share, or 27.34%, closing at $2.02 per share on the same day [2]

Core Viewpoint - Canopy Growth Corp.'s stock experienced a significant decline of 9%, reaching an all-time low, following the announcement of a plan to sell up to $200 million of its stock [1] Group 1: Stock Performance - The stock of Canopy Growth Corp. fell by 9% [1] - This decline resulted in the stock reaching an all-time low [1] Group 2: Stock Offering Details - The company plans to sell up to $200 million of its stock [1] - This stock offering would nearly double the dollar amount of its stock currently trading on the Nasdaq and the Toronto Stock Exchange, given the company's market capitalization of approximately $240 million [1]

Core Viewpoint - Canopy Growth Corporation has launched a new at-the-market equity program allowing the issuance and sale of up to US$200 million of common shares to support corporate purposes, including debt repayment and strategic acquisitions [1][2]. Group 1: ATM Program Details - The ATM Program enables Canopy Growth to issue and sell common shares in public offerings in the U.S. and Canada, with sales conducted at prevailing market prices [1]. - The program will remain effective until the earlier of the sale of all shares, regulatory notice of cessation of effectiveness, or July 5, 2026, unless terminated earlier [3]. - The offering is qualified by a prospectus supplement filed with Canadian and U.S. securities regulators [4]. Group 2: Use of Proceeds - Net proceeds from the ATM Program will be utilized for investments in businesses, potential acquisitions, working capital, and general corporate purposes, including a US$100 million optional prepayment under the existing credit agreement [2]. Group 3: Company Overview - Canopy Growth is a leading cannabis company focused on improving lives through cannabis products, with operations in Canada, Germany, Poland, and Australia [6][7]. - The company has established a comprehensive ecosystem to capitalize on the U.S. THC market through non-controlling interests in Canopy USA, which includes ownership stakes in Acreage Holdings and Wana Brands [8].

Core Viewpoint - Pomerantz LLP is investigating claims of potential securities fraud or unlawful business practices involving Canopy Growth Corporation and its officers or directors [1] Financial Performance - On February 7, 2025, Canopy Growth Corporation reported its financial results for the third quarter of fiscal year 2025, showing year-over-year declines in both net revenue and gross margin, leading to a wider-than-expected net loss for the quarter [2] - Following the financial report, Canopy's stock price dropped by $0.76 per share, or 27.34%, closing at $2.02 per share on the same day [2]

Canadian Gold Corp. Tartan Mine: Western Expansion Drilling Intersects More High-Grade of 11.6 gpt Gold Over 5.1 Metres & 7.1 gpt Over 6.0 MetresFebruary 18, 2025 8:00 AM EST | Source: Canadian Gold Corp.Toronto, Ontario--(Newsfile Corp. - February 18, 2025) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company"), is pleased to announce ongoing drill results from its Phase 4 drill program at the Tartan Mine, near Flin Flon, Manitoba. Two holes successfully expanded the high-grade ...